跳至主要内容
临床试验/JPRN-jRCTs061190024
JPRN-jRCTs061190024已完成未知

Retinal amyloid deposition in Alzheimer's disease patients - Retinal amyloid in Alzheimer's disease

Yamashita Toru0 个研究点目标入组 37 人开始时间: 2019年11月25日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
37

研究概览

简要总结

The present noninvasive in vivo detection of retinal amyloid deposition is useful for screening AD patients.

研究设计

研究类型
Interventional

入排标准

年龄范围
>= 65age old 至 < 85age old(—)
性别
All

入选标准

  • 1. Outpatient of the neurology department of our clinic
  • 2. Diagnosed as Alzheimer's disease, mild cognitive impairment(MCI), or normal cognitive function (except for complication of vascular dementia)
  • 3. Native Japanese speaker
  • 4. Age from 65 to 84

排除标准

  • 1. Impossible to take crucumin supplement due to severe dysphagia
  • 2. Diagnosed as closed-angle glaucoma, and impossible to use mydriatic agent
  • 3. Severe visual impairment requiring daily support
  • 4. Unable to take curcumin supplement or examination due to severe cognitive decline
  • 5. Judged by researchers not to be eligible

研究者

发起方
Yamashita Toru

相似试验